Altair Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2007-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.altairthera.com
Clinical Trials
2
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)Study Evaluating the Effects of AIR645 on Allergen-Induced Airway Responses in Subjects With Mild Atopic Asthma
- First Posted Date
- 2009-07-17
- Last Posted Date
- 2010-07-23
- Lead Sponsor
- Altair Therapeutics, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT00941577
A Phase 1 Study of AIR645 in Healthy Subjects and Subjects With Controlled Asthma
- First Posted Date
- 2008-04-15
- Last Posted Date
- 2009-06-25
- Lead Sponsor
- Altair Therapeutics, Inc.
- Target Recruit Count
- 80
- Registration Number
- NCT00658749
- Locations
- 🇺🇸
Contract Research Organization (CRO) appointed by Altair Therapeutics--Altair's offices are in:, San Diego, California, United States
News
No news found